Delivery Order SPE2DB22D3009-SPE2DB24FBD97

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order valued at $15,665.82 for the supply of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products. The contract is awarded by the Defense Logistics Agency (DLA), a major defense agency that procures and distributes supplies and equipment to the U.S. military. The award has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, one of the largest...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,991.51 firm fixed-price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,947.85 firm fixed-price delivery order covers the supply of the pharmaceutical product BRIDION 200 MG/2 ML VIAL 2ML. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,107.18 firm fixed price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,971.98 Firm Fixed Price Delivery Order contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The $22,863.56 firm fixed price contract has a completion date of June 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $17,721.91 firm fixed-price delivery order is for the supply of BRIDION 500 MG/5 ML VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts (IDCs) with the federal government - a $999,999,999.00 single-award IDC with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,535.42 firm fixed-price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a critical medical product. The contract has an ultimate completion date of January 23, 2025 and was awarded on January 22, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $11,159.50 firm fixed price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products. The contract has a period of performance through September 13, 2024 and is not set aside for any specific business category. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,186.99 Firm Fixed Price Delivery Order covers the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through October 31, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBD97
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $12,884.23 firm-fixed-price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as several other Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation, collectively valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs, veterans' healthcare, and other federal beneficiaries. The contract does not have a set-aside designation.

Generated 11/25/24, 9:03 AM